A trial of benzhydrocodone in patients with acute pain

Trial Profile

A trial of benzhydrocodone in patients with acute pain

Planning
Phase of Trial: Phase II

Latest Information Update: 29 Nov 2016

At a glance

  • Drugs Benzhydrocodone (Primary)
  • Indications Acute pain
  • Focus Therapeutic Use
  • Most Recent Events

    • 29 Nov 2016 According to KemPharm media release, Investigational New Drug (IND) application for KP201/IR has been accepted by the U.S. Food and Drug Administration (FDA) and remain on target for a potential submission in 2018 of the KP201/IR New Drug Application (NDA) and remain on target for a potential submission of New Drug Application (NDA) in 2018.
    • 25 Oct 2016 According to a KemPharm media release, the company has filed an Investigational New Drug (IND) application with the U.S. Food and Drug Administration (FDA) for KP-201.
    • 15 Sep 2016 According to KemPharm media release, this trial is expected to initiate in the first quarter of 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top